期刊文献+

脓毒症合并急性肾损伤患者的临床特点与预后 被引量:13

Clinical characteristics and prognosis in patients with septic and acute kidney injury
下载PDF
导出
摘要 目的:研究脓毒症合并急性肾损伤(AKI)患者的临床特点与预后。方法:收集我院2008年1月~2011年6月收治的124例脓毒症合并AKI患者的临床资料,同期非脓毒症合并AKI患者280例作为对照组,分析脓毒症合并AKI组患者的临床特点及预后。结果:脓毒症合并AKI患者中,感染部位主要为肺部(50.0%)和腹部(29.0%)。脓毒症与非脓毒症AKI患者相比,两者的APACHEll评分、平均动脉压,机械通气、血管活性药物应用的比例,器官衰竭数≥3个者等指标的比较差异有统计学意义(P〈0.05)。RIFLE不同分级中脓毒症合并AKI患者的病死率分别是R组60.0%、I组66.7%、F组73.5%,较非脓毒症组比较差异有统计学意义(P〈0.05)。非脓毒症与脓毒症AKI患者的总住院病死率分别为37.8%、68.5%,差异有统计学意义(P〈0.01)。结论:脓毒症AKI患者与非脓毒症AKI患者相比,临床各项指标更差,有更高的临床病死率。 Objective. To investigate the clinical characteristics and prognosis in patients with acute kidney injury (AKI) due to sepsis. Methods, A case-control retrospective study was carried out in AKI pa tients with/without sepsis from January 2008 to June 2011. Clinical characteristics and prognosis in pa- tients with septic AKI were analyzed. Results- The most common site of infection for AKI patients with sepsis were lungs (50.0%)and abdomen (29.0%). Patients with sepsis had significantly higher APACHE II scores, higher rates of mechanical ventilation, organ failure≥3 and lower mean artery pressure than pa- tients without sepsis. Based on RIFLE criteria, the mortality rate was 60.0%for R group, 66. 7% for I group and 73.5%for F group in patients with sepsis which were much higher than in patients without sep- sis. AKI patients with sepsis also has higher total mortality rate (68.50/00 vs. 37.8%,P〈0.01). Oonclu- tion.. Compared with the patients without sepsis, patients with sepsis have worse clinical parameters and a higher inhospital mortality.
出处 《海南医学院学报》 CAS 2013年第12期1694-1696,共3页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210902)~~
关键词 脓毒症 急性肾损伤 预后 Sepsis Acute kidney Prognosis
  • 相关文献

参考文献10

  • 1Protii A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunc- tion in sepsis-induced organ failure[J]. Crit Care,2006, 10(5) : 228-234.
  • 2Chertow G M,Burdiek E, Honour M, et al. Acute kid- ney injury mortality,length of stay, and costs in hospi- talized patients[J]. J Am Soc Nephrol, 2005,16 (11) : 3365-3370.
  • 3Rabb H. Immune modulation of acute kidney injury[J]. J Am Soc Nephrol,2006,17 : 604-606.
  • 4Fliter MA,Schreiber H, Huber-Lang MS. The role of complement,C5a and its receptors in sepsis and mul- tiorgan dysfunction syndrome[J]. J Invest Surg,2006, 19(4) :1448.
  • 5Park WY, Hwang EA,Jang MH,et al. The risk factors and outcome of acute kidney injury in the intensive care units[J]. Koren J Intern Med,2010,25(2) : 181-187.
  • 6Silva- J(mior GB, Daher -Ede F, Mota RM, et al. Risk factors for death among critically ill patients with acute renal failure[J]. Sao Paulo Med J, 2006,124 (5) : 257- 263.
  • 7岳金凤,吴大玮,李琛,翟茜,陈晓梅,丁士芳,杜滨峰,李远.以急性肾损伤网络标准评估重症监护病房患者急性肾损伤的发病率、预后及死亡相关危险因素[J].中华医学杂志,2011,91(4):260-264. 被引量:28
  • 8Shigehiko U, Rinaldo B, Donna G, et al. Assesment of the RIFLE criteria for acute renal failure in hospitalized patients[J]. Crit Care Med,2006 ,34(7) :1913-1917.
  • 9Klenzak J, Himmelfarb J. Sepsis and the kidney[J]. Crit Care Clin,2005 ,21(2) :211-222.
  • 10Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE[J]. Crit Care Med, 2007,35 : 1837-1843.

二级参考文献17

  • 1Brivet FG,Kleinkneeht DJ,Loirat P,et al.Acute renal failure in intensive care units-causes,outcome,and prognostic factors of hospital mortality;a prospective,multicenter study.French Study Group on Acute Renal Failure.Crit Care Med,1996,24:192-198.
  • 2Cole L,Bellomo R,Silvester W,et al.A prospective,multicenter study of the epidemiology,management,and outcome of severe acute renal failure in a "closed" ICU system.Am J Respir Crit Care Med,2000,162:191-196.
  • 3Singri N,Ahya SN,Levin ML.Acute renal failure.JAMA,2003,289:745 -751.
  • 4Hoste EA,Clermont G,Kersten A,et al.RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients:a cohort analysis.Crit Care,2006,10:R73.
  • 5Uchino S,Bellomo R,Goldsmith D,et al.An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.Crit Care Med,2006,34:1913-1917.
  • 6Bagshaw SM,George C,Dinu I,et al.A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients.Nephrol Dial Transplant,2008,23:1203-1210.
  • 7Bellomo R,Kellum J,Ronco C.Acute renal failure:time for consensus.Intensive Care Med,2001,27:1685-1688.
  • 8Bellomo R,Kellum JA,Ronco C.Defining and classifying acute renal failure:from advocacy to consensus and validation of the RIFLE criteria Intensive Care Med,2007,33:409-413.
  • 9Bellomo R,Ronco C,Kellum JA,et al.Acute renal failuredefinition,outcome measures,animal models,fluid therapy and information technology needs:the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)Group.Crit Care,2004,8:R204-R212.
  • 10Mehta RL,Kellum JA,Shah SV,et al.Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury.Crit Care,2007,11:R31.

共引文献27

同被引文献104

  • 1Tanaka R, Fujita M, Tsuruta R, et al. Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats[J]. Inflamm Res,2010,59(8) :597-603.
  • 2Kim SJ, Yoo KY. Urinary trypsin inhibitors afford car- dioprotective effects through activation of PI3K-Akt and ERK signal transduction and inhibition of p38 MAPK and JNK[J]. Cardiology,2009,114(4) :264-269.
  • 3Bao P, Gao W, Li S, et al. Effect of pretreatment with high-dose ulinastatin in preventing radiation-induced pulmonary injury in rats[J]. Eur J Pharmacol, 2009, 603(1-3) :114-117.
  • 4Shigehiko U, Rinaldo B, Donna G, et al. Assesment of the RIFLE criteria for acute renal failure in hospitalized patients[J]. Crit Care Med, 2006 , 34(7) : 1913-1917.
  • 5Park W Y,Hang E A,Jang M H,et al. The risk factors and outcome of acute kidney injury in the intensive care units[J]. Koren J Intern Med, 2010,25 (2) : 181-187.
  • 6Marshall J C.Inflammation,coagulopathy,and the pathogenesis of multiple organ dysfunction syndrome[J].Crit Care Med,2001,29(7):99.
  • 7Marshall J C,Cook D J,Christou N V,et al.Multiple organ dysfunction score:a reliable descriptor of a complex clinical outcome[J].Crit Care Med,1995,23(10):1638.
  • 8Kinasewitz G T,Yan S B,Basson B,et al.Universal changes in biomakers of coagulation and inflamation occur in patients with severe sepsis,regardless of causative microrganism[J].Crit Care,2004,8(2):82.
  • 9tlausenloy DJ. Urinary trypsin inhibition: cardioprotection via the reperfusion injury salvage kinase pathway [J ]. Cardiology. 2009. 114(4) :261-263.
  • 10Kim S J, Too KT, Jcong CW, et al. Urinary trpsin inhihitors afford cardioproteetive effects through activation of PI3K - Akt and L, RK signal Lransduelion and inhihition of X38 MA1 K and JNK [J].Cardiology,2009,114(4):26-270.

引证文献13

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部